Synthetic Nucleic Acid Antigens in Localized Scleroderma

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Localized scleroderma is an autoimmune skin disease.
• Anti-DNA antibodies are common in autoimmune conditions like lupus and localized scleroderma.
• The specific sequence of nucleic acid antigens may influence autoimmune responses.

Purpose of the Study:

• To investigate the impact of synthetic nucleic acid antigen sequences on autoantibody profiles in localized scleroderma.
• To determine if specific nucleic acid sequences correlate with disease activity.
• To explore potential diagnostic markers for localized scleroderma.

Main Methods:

• Synthesized a panel of DNA and RNA antigens.
• Performed autoantibody profiling in 70 children with localized scleroderma, healthy controls, and pediatric lupus patients.
• Utilized a bleomycin-induced mouse model to confirm in vivo findings.

Main Results:

• A synthetic DNA antigen, dsD4 (containing the BRAF oncogene sequence), showed a strong presence in localized scleroderma patients, unlike in systemic lupus erythematosus.
• dsD4 autoantibody levels significantly correlated with disease activity in localized scleroderma patients.
• In vivo administration of dsD4 induced a polyclonal response in a mouse model.

Conclusions:

• Nucleic acid antigen sequence specificity plays a role in localized scleroderma autoimmunity.
• dsD4 autoantibodies represent a potential biomarker for localized scleroderma.
• Findings suggest possibilities for novel early-stage diagnostic tools for localized scleroderma.